Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://nanahdga666693.jaiblogs.com/65952555/retaglutide-a-promising-glp-1-receptor-agonist